Concepedia

Author

Paul Pagano

Pfizer (United States)

Also Known As

P.J. Pagano, Paul J Pagano, Paul J. Pagano, Paul Pagano

10

Publications

180

Citations

8

H-Index

23

Concepts

All Affiliations

Pfizer (United States)
PP

About

Paul Pagano is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

142

2

Biochemistry

4

4

91

3

Natural Sciences

2

2

44

4

Health Sciences

1

1

19

5

Immunology

1

1

15

Paul Pagano

×

8

Publications

179

Citations

8

H-Index

YearCitations

Efficacy of Linezolid plus Rifampin in an Experimental Model of Methicillin-Susceptible <i>Staphylococcus aureus</i> Endocarditis

Charlene F. Dailey, Paul Pagano, Lewis V. Buchanan,

Antimicrobial Agents and Chemotherapy

2003

37

Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC

Joseph S. Warmus, Cheryl L. Quinn, Clarke Taylor,

Bioorganic & Medicinal Chemistry Letters

2012

32

Antibacterial Oxazolidinones Possessing a Novel C-5 Side Chain. (5<i>R</i>)-<i>trans</i>-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic Acid Amide (PF-00422602), a New Lead Compound

Toni‐Jo Poel, Richard C. Thomas, Wade J. Adams,

Journal of Medicinal Chemistry

2007

28

Effects of linezolid on staphylococcal adherence versus time of treatment

Paul Pagano, Lewis V. Buchanan, Charlene F. Dailey,

International Journal of Antimicrobial Agents

2004

19

Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution

Cindy L. Wolfe, Paul Pagano, Chris M. Pillar,

Diagnostic Microbiology and Infectious Disease

2018

17

Characterization of <scp>d</scp>‐boroAla as a Novel Broad‐Spectrum Antibacterial Agent Targeting <scp>d</scp>‐Ala‐<scp>d</scp>‐Ala Ligase

Sandeep Putty, Aman Rai, Darshan Jamindar,

Chemical Biology & Drug Design

2011

16

Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine1This paper was presented in part at the Tenth International Conference on AIDS, Yokohama, Japan, August 1994. Abstract No. PAO-314.1

Kong-Teck Chong, Paul Pagano

Antiviral Research

1997

15

Synthesis and structure–activity studies of novel homomorpholine oxazolidinone antibacterial agents

Jiyoung Kim, F Boyer, Allison L. Choy,

Bioorganic & Medicinal Chemistry Letters

2008

15

Page 1